Skip to main content
. 2016 Oct 20;11(2):124–139. doi: 10.1002/1878-0261.12012

Figure 1.

Figure 1

Locations of tumors and biopsies sampled and general study workflow. (a) Locations of tumors and tissue sectors. Multiple tumor Sectors A, B, C, D, and E, and a nonmalignant Sector N, were taken from the locations shown. (b) A combination of mutational profiling (by the targeted capture sequencing and ultra‐deep amplicon sequencing), copy number alteration profiling (by ASCAT and NanoString Copy Number Assay), and gene expression profiling (by NanoString Pan Cancer Pathways Panel Assay) was employed in this study.